{"infobox":{"dc_creator":"WooScraper_v1","dc_date_year":2020,"dc_identifier":"nl.oorg10123.2j.2020.200","dc_publisher":"oorg10123","dc_publisher_name":"Rijksinstituut voor Volksgezondheid en Milieu","dc_source":"https://www.rivm.nl/publicaties/safety-and-immunogenicity-of-quadrivalent-human-papillomavirus-vaccine-in-patients-with","dc_title":"Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study. | RIVM","dc_type":"2j","dc_type_description":"2j - Onderzoek","foi_extraMetadata":{},"foi_files":[],"foi_isWoo":"Ja","foi_page_title":"Onderzoek Rijksinstituut voor Volksgezondheid en Milieu","foi_publishedDate":"2020-06-08","foi_retrievedDate":"2024-11-30","tooiwl_type":"c_fdaee95e"},"resource":"nl.oorg10123.2j.2020.200"}